Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Thursday, April 25, 2024
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
admin
-
March 8, 2024
Latest Pharma-News
FDA Clears First Over-the-Counter Continuous Glucose Monitor
admin
-
March 8, 2024
Latest Pharma-News
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
admin
-
March 1, 2024
Latest Pharma-News
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
admin
-
February 3, 2024
Latest Pharma-News
BlueRock Therapeutics exercises exclusive option to license iPSC cell therapy candidate OpCT-001 for Primary Photoreceptor Diseases
admin
-
February 1, 2024
Latest Pharma-News
Soligenix initiates phase 1C, double-blind, placebo-controlled, phase 1C trial of RiVax, a lyophilized ricin toxin A-chain subunit vaccine with alum-adjuvant
admin
-
December 17, 2019
0
Latest Pharma-News
ViiV Healthcare files submissions to the FDA and EMA for the first-ever dispersible formulation of dolutegravir DTG 50mg film-coated tablet (FCT) in paediatric HIV...
admin
-
December 16, 2019
0
Latest Pharma-News
FDA Approved Amarin’s Vascepa For the cardiovascular problems, Shares Up 5%
admin
-
December 16, 2019
0
Latest Pharma-News
Trastuzumab deruxtecan (DS-8201), accomplished the tumour response rate of 60.9% in pivotal Phase II HER2-positive metastatic breast cancer trial
admin
-
December 13, 2019
0
Latest Pharma-News
First Ever Randomized Phase 3 Clinical Trial (LIBRETTO-431) for the Treatment of Naïve RET Fusion-Positive Non-Small Cell Lung Cancer
admin
-
December 13, 2019
0
Latest Pharma-News
EVENITY® (romosozumab) approved by European Commission (EC) for the treatment of severe osteoporosis in postmenopausal women at high risk of fracture
admin
-
December 13, 2019
0
Latest Pharma-News
U.S. FDA OKs for Pfizer’s XELJANZ® XR (tofacitinib) Extended-Release Tablets for the Treatment of Ulcerative Colitis
admin
-
December 13, 2019
0
Latest Pharma-News
The U.S. Food and Drug Administration granted accelerated approval for the first targeted treatment, Vyondys 53 (golodirsen) injection to treat Duchenne muscular dystrophy
admin
-
December 13, 2019
0
Latest Pharma-News
Innovative diabetes management solution (Accu-Chek SugarView app) announced by Roche
admin
-
December 11, 2019
0
Latest Pharma-News
Daiichi Sankyo Initiates Pivotal Phase 2 Trial in Japan with Valemetostat to treat patients with adult T-cell leukemia-lymphoma
admin
-
December 11, 2019
0
Latest Pharma-News
Healx collaborates with Boehringer Ingelheim to discover new treatment approaches for rare neurological diseases
admin
-
December 11, 2019
0
Latest Pharma-News
GenesisCare launched UK’s first MRIdian radiotherapy machine: a new radiotherapy treatment to reduce treatment time
admin
-
December 11, 2019
0
1
...
136
137
138
...
144
Page 137 of 144
- Advertisment -
Most Read
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
March 8, 2024
FDA Clears First Over-the-Counter Continuous Glucose Monitor
March 8, 2024
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
March 1, 2024
Regulatory Applications Accepted in the U.S. and Japan for BMS Breyanzi in Relapsed or Refractory FL and Relapsed or Refractory MCL
February 3, 2024